Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
Upgrades
According to Macquarie, the prior rating for Lufax Holding Ltd (NYSE:LU) was changed from Underperform to Outperform. For the fourth quarter, Lufax Holding had an EPS of $0.05, compared to year-ago quarter EPS of $0.19. The current stock performance of Lufax Holding shows a 52-week-high of $7.05 and a 52-week-low of $1.26. Moreover, at the end of the last trading period, the closing price was at $1.64.
Barrington Research upgraded the previous rating for Warner Bros. Discovery Inc (NASDAQ:WBD) from Market Perform to Outperform. For the first quarter, Warner Bros. Discovery had an EPS of $0.44, compared to year-ago quarter EPS of $0.69. The current stock performance of Warner Bros. Discovery shows a 52-week-high of $18.76 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $12.81.
According to Exane BNP Paribas, the prior rating for NEXTracker Inc (NASDAQ:NXT) was changed from Neutral to Outperform. At the moment, the stock has a 52-week-high of $40.50 and a 52-week-low of $28.24. NEXTracker closed at $40.32 at the end of the last trading period.
Argus Research upgraded the previous rating for Royal Caribbean Group (NYSE:RCL) from Hold to Buy. Royal Caribbean Gr earned $0.23 in the first quarter, compared to $4.57 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.38 and a 52-week-low of $31.09. Royal Caribbean Gr closed at $76.12 at the end of the last trading period.
According to Argus Research, the prior rating for Canadian Pacific Kansas City Ltd (NYSE:CP) was changed from Hold to Buy. For the first quarter, Canadian Pacific Kansas had an EPS of $0.90, compared to year-ago quarter EPS of $0.53. The current stock performance of Canadian Pacific Kansas shows a 52-week-high of $83.18 and a 52-week-low of $65.22. Moreover, at the end of the last trading period, the closing price was at $82.93.
Keefe, Bruyette & Woods upgraded the previous rating for Ellington Financial Inc (NYSE:EFC) from Market Perform to Outperform. In the first quarter, Ellington Financial showed an EPS of $0.45, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.37 and a 52-week-low of $10.81. Ellington Financial closed at $12.46 at the end of the last trading period.
Deutsche Bank upgraded the previous rating for Veris Residential Inc (NYSE:VRE) from Hold to Buy. In the first quarter, Veris Residential showed an EPS of $0.15, compared to $0.09 from the year-ago quarter. The current stock performance of Veris Residential shows a 52-week-high of $17.69 and a 52-week-low of $10.21. Moreover, at the end of the last trading period, the closing price was at $16.24.
According to Gordon Haskett, the prior rating for Expedia Group Inc (NASDAQ:EXPE) was changed from Hold to Buy. For the first quarter, Expedia Group had an EPS of $0.20, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $135.35 and a 52-week-low of $82.39. Expedia Group closed at $92.23 at the end of the last trading period.
For NovoCure Ltd (NASDAQ:NVCR), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. NovoCure earned $0.50 in the first quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $120.03 and a 52-week-low of $56.05. NovoCure closed at $77.82 at the end of the last trading period.
According to Citigroup, the prior rating for Williams Companies Inc (NYSE:WMB) was changed from Neutral to Buy. In the first quarter, Williams Companies showed an EPS of $0.56, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.95 and a 52-week-low of $27.80. Williams Companies closed at $29.10 at the end of the last trading period.
For Gilead Sciences Inc (NASDAQ:GILD), BMO Capital upgraded the previous rating of Market Perform to Outperform. Gilead Sciences earned $1.37 in the first quarter, compared to $2.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $89.61 and a 52-week-low of $57.17. Gilead Sciences closed at $78.38 at the end of the last trading period.
According to Barclays, the prior rating for Amdocs Ltd (NASDAQ:DOX) was changed from Equal-Weight to Overweight. Amdocs earned $1.47 in the second quarter, compared to $1.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $97.08 and a 52-week-low of $76.79. Amdocs closed at $91.01 at the end of the last trading period.
For Palomar Holdings Inc (NASDAQ:PLMR), Keefe, Bruyette & Woods upgraded the previous rating of Market Perform to Outperform. For the first quarter, Palomar Hldgs had an EPS of $0.80, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $95.01 and a 52-week-low of $43.64. At the end of the last trading period, Palomar Hldgs closed at $47.11.
New Street Research upgraded the previous rating for America Movil SAB de CV (NYSE:AMX) from Neutral to Buy. For the first quarter, America Movil had an EPS of $0.51, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $22.93 and a 52-week-low of $15.68. At the end of the last trading period, America Movil closed at $22.81.
See all analyst ratings upgrades.
Downgrades
For Absolute Software Corp (NASDAQ:ABST), TD Securities downgraded the previous rating of Buy to Tender. At the moment, the stock has a 52-week-high of $12.57 and a 52-week-low of $7.39. Absolute Software closed at $11.33 at the end of the last trading period.
For NeoGames SA (NASDAQ:NGMS), Truist Securities downgraded the previous rating of Buy to Hold. In the first quarter, NeoGames showed an EPS of $0.20, compared to $0.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.50 and a 52-week-low of $10.85. NeoGames closed at $27.17 at the end of the last trading period.
For NeoGenomics Inc (NASDAQ:NEO), Raymond James downgraded the previous rating of Outperform to Market Perform. For the first quarter, NeoGenomics had an EPS of $0.09, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $20.54 and a 52-week-low of $6.00. NeoGenomics closed at $19.13 at the end of the last trading period.
For CTI BioPharma Corp (NASDAQ:CTIC), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the first quarter, CTI BioPharma showed an EPS of $0.10, compared to $0.37 from the year-ago quarter. The current stock performance of CTI BioPharma shows a 52-week-high of $8.96 and a 52-week-low of $3.95. Moreover, at the end of the last trading period, the closing price was at $8.93.
Morgan Stanley downgraded the previous rating for Cullen/Frost Bankers Inc (NYSE:CFR) from Overweight to Equal-Weight. Cullen/Frost Bankers earned $2.70 in the first quarter, compared to $1.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of $160.31 and a 52-week-low of $92.55. Cullen/Frost Bankers closed at $99.63 at the end of the last trading period.
Morgan Stanley downgraded the previous rating for Prosperity Bancshares Inc (NYSE:PB) from Equal-Weight to Underweight. Prosperity Bancshares earned $1.37 in the first quarter, compared to $1.33 in the year-ago quarter. The current stock performance of Prosperity Bancshares shows a 52-week-high of $78.76 and a 52-week-low of $56.72. Moreover, at the end of the last trading period, the closing price was at $60.64.
According to Morgan Stanley, the prior rating for Commerce Bancshares Inc (NASDAQ:CBSH) was changed from Equal-Weight to Underweight. In the first quarter, Commerce Bancshares showed an EPS of $0.95, compared to $0.97 from the year-ago quarter. At the moment, the stock has a 52-week-high of $71.87 and a 52-week-low of $48.01. Commerce Bancshares closed at $49.75 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
JonesTrading initiated coverage on Vor Biopharma Inc (NASDAQ:VOR) with a Buy rating. The price target for Vor Biopharma is set to $18.00. In the first quarter, Vor Biopharma showed an EPS of $0.43, compared to $0.61 from the year-ago quarter. The current stock performance of Vor Biopharma shows a 52-week-high of $7.53 and a 52-week-low of $3.50. Moreover, at the end of the last trading period, the closing price was at $4.42.
Truist Securities initiated coverage on Rayonier Inc (NYSE:RYN) with a Hold rating. The price target for Rayonier is set to $33.00. For the first quarter, Rayonier had an EPS of $0.01, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $41.96 and a 52-week-low of $27.81. At the end of the last trading period, Rayonier closed at $29.91.
With a Hold rating, Truist Securities initiated coverage on Ardagh Metal Packaging SA (NYSE:AMBP). The price target seems to have been set at $4.00 for Ardagh Metal Packaging. For the first quarter, Ardagh Metal Packaging had an EPS of $0.01, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $7.00 and a 52-week-low of $3.44. At the end of the last trading period, Ardagh Metal Packaging closed at $3.59.
With an Outperform rating, Oppenheimer initiated coverage on GE HealthCare Technologies Inc (NASDAQ:GEHC). The price target seems to have been set at $97.00 for GE HealthCare Techs. For the first quarter, GE HealthCare Techs had an EPS of $0.85, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of $87.83 and a 52-week-low of $53.00. At the end of the last trading period, GE HealthCare Techs closed at $74.93.
With a Hold rating, Berenberg initiated coverage on Coinbase Global Inc (NASDAQ:COIN). The price target seems to have been set at $55.00 for Coinbase Glb. Coinbase Glb earned $0.34 in the first quarter, compared to $1.98 in the year-ago quarter. At the moment, the stock has a 52-week-high of $116.30 and a 52-week-low of $31.55. Coinbase Glb closed at $60.77 at the end of the last trading period.
